The association between blood sugar control and hearing impairment in individuals with type 2 diabetes mellitus: a prospective study using otoacoustic emissions as a biomarker
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20232218Keywords:
Blood sugar, Hearing impairment, Type 2 diabetes mellitus, Otoacoustic emissionsAbstract
Background: The existing association between hearing impairment and diabetes mellitus (DM) prompted us to investigate the relationship between glycaemic control, as measured by HbA1c levels, and hearing impairment in individuals with type 2 diabetes mellitus (T2DM).
Methods: In this study, we assessed the auditory function of a sample of 100 individuals diagnosed with T2DM, who were aged 30 years or older and had a disease duration of at least 5 years. The evaluation was conducted using distortion product otoacoustic emissions and transient evoked otoacoustic emissions. The criteria for poor glycaemic control were established as HbA1c levels equal to or exceeding 7.5%.
Results: Individuals with a haemoglobin A1c (HbA1c) level of 7.5% or higher exhibited a nearly threefold increased likelihood of developing hearing impairment in comparison to those with lower HbA1c levels. The gender-based observation revealed a stronger association in females, although the observed correlation did not reach statistical significance.
Conclusions: The findings of our study establish a significant association between inadequate management of blood glucose levels and the occurrence of hearing impairment among individuals with T2DM. These results underscore the importance of achieving optimal glycaemic control as a means of preventing hearing impairment in this patient population. Further investigation is required to substantiate these findings through a comprehensive and longitudinal research approach.
References
Bainbridge KE, Hoffman HJ, Cowie CC. Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004. Ann Intern Med. 2008;149(1):1-10.
Cruickshanks KJ, Klein R, Klein BE, Wiley TL, Nondahl DM, Tweed TS. Cigarette smoking and hearing loss: the epidemiology of hearing loss study. JAMA. 1998;279(21):1715-9.
Mitchell P, Gopinath B, McMahon CM, Rochtchina E, Wang JJ, Boyages SC, et al. Relationship of Type 2 diabetes to the prevalence, incidence and progression of age-related hearing loss. Diabet Med. 2009;26(5): 483-8.
Horikawa C, Kodama S, Tanaka S, Fujihara K, Hirasawa R, Yachi Y, et al. Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol Metab. 2013;98(1):51-8.
Mitchell P, Gopinath B, McMahon CM, Rochtchina E, Wang JJ, Boyages SC, et al. Relationship of Type 2 diabetes to the prevalence, incidence and progression of age-related hearing loss. Diabet Med. 2009;26(5): 483-8.
Sasso FC, Salvatore T, Tranchino G, Cozzolino D, Caruso AA, Persico M, et al. Cochlear dysfunction in type 2 diabetes: a complication independent of neuropathy and acute hyperglycemia. Metabolism. 1999;48(11):1346-50.
Dedov I, Shestakova M, Benedetti MM, Simon D, Pakhomov I, Galstyan G. Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study). Diabetes Res Clin Pract. 2016;115: 90-5.
Zafar A, Davies M, Azhar A, Khunti K. Clinical inertia in management of T2DM. Prim Care Diab. 2010; 4(4):203-7.
American Diab Assoc. Standards of Medical Care in Diabetes-2017 Abridged for Primary Care Providers. Clin Diab. 2017;35(1):5-26.
American Speech-Language-Hearing Association Beyond infant hearing screening with otoacoustic emissions. Available at: https://www.asha.org/ public/hearing/Otoacoustic-Emissions-Beyond-Newborn-HearingScreening. Accessed on 20 February 2023.
Srinivas CV, Shyamala V, Shiva Kumar BR. Clinical study to evaluate the association between sensorineural hearing loss and diabetes mellitus in poorly controlled patients Whose HbA1c >8. Indian J Otolaryngol Head Neck Surg. 2016;68(2):191-5.
Oh IH, Lee JH, Park DC, Kim M, Chung JH, Kim SH, Yeo SG. Hearing loss as a function of aging and diabetes mellitus: a cross sectional study. PLoS One. 2014;9(12):e116161.
Agrawal Y, Platz EA, Niparko JK. Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999-2004. Arch Intern Med. 2008;168(14):1522-30.
Gopinath B, Schneider J, McMahon CM, Teber E, Leeder SR, et al. Severity of age-related hearing loss is associated with impaired activities of daily living. Age Ageing. 2012;41(2):195-200.
Helzner EP, Cauley JA, Pratt SR, Wisniewski SR, Zmuda JM, Talbott EO, et al. Race and sex differences in age-related hearing loss: the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005;53(12): 2119-27.
Asma A, Azmi MN, Mazita A, Marina MB, Salina H, Norlaila M. A single blinded randomized controlled study of the effect of conventional oral hypoglycemic agents versus intensive short-term insulin therapy on pure tone audiometry in type ii diabetes mellitus. Indian J Otolaryngol Head Neck Surg. 2011;63(2):114-8.
Wang W, Zhang C, Meng R, Zhan S, Wang S, Feng L, Song Y. Sex-specific associations between diabetes mellitus and hearing loss in the middle-aged and elderly individuals: a national cohort study of chinese adults. Endocr Pract. 2022;28(4):357-63.
